Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Lower SHBG levels may increase the risk of PCOS.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.

An imbalanced gut and lack of biotin can cause hair loss in mice.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Some common medications can harm male fertility, but many effects can be reversed.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

NIR light therapy may effectively treat eye diseases and improve brain function without side effects.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

SHBG may be a useful early indicator and treatment target for PCOS.

Testosterone may slow down wound healing and increase inflammation.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.